Finasteride NEW
| Price | $35 | $48 | $80 |
| Package | 50mg | 100mg | 200mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Finasteride | CAS No.: 98319-26-7 |
| Purity: 99.93% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Finasteride |
| Description | Finasteride (MK-906) is an oral inhibitor of active testosterone 5-alpha-reductase and Ki value is 10 nM. |
| In vitro | After 4, 9, 14, and 21 days, rat prostates were excised to measure androgen and DNA content and to undergo histological and morphological analyses. On day 21, finasteride levels decreased by 65%. Finasteride treatment induced a dose-dependent increase in the incidence of hypospadias (penischisis) in male offspring, with a threshold dose level of approximately 0.1 mg/kg/day and a 100% effect level at 100 mg/kg/day (administered on gestational day 20). Additionally, finasteride reduced the anogenital distance in male offspring rats. After 4 days of treatment with finasteride, DNA content was almost unaffected, but a decrease of up to 52% was observed at 14 days. After prostate sections were stained, 23% of epithelial cells displayed markers of apoptotic cell death on day 14, returning to control levels by day 21. Finasteride caused 16% of epithelial cells to stain for tissue transglutaminase on day 9, with a return to baseline by day 14. Finasteride-induced staining was less intense at 4 days, peaking at 0.7% of epithelial cells and returning to control values by day 9. |
| In vivo | Finasteride inhibits the growth rate of prostate lymph node carcinoma cell lines in a dose-dependent manner and significantly suppresses the secretion and expression of prostate-specific antigen in LNCaP cells. It forms a ternary complex with the reduced coenzyme II of type 2 isoenzyme (Ki: 1.19 nM), which then rearranges into a high-affinity complex (E:Ⅰ) with an approximate first-order rate constant of 1.62ms. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : 37.3 mg/mL (100.12 mM), Sonication is recommended. DMSO : 64 mg/mL (171.79 mM), Sonication is recommended. |
| Keywords | type | prostatic | MK906 | MK 906 | Inhibitor | inhibit | hyperplasia | Finasteride | BPH | benign | androgenic | alopecia | 5α-reductase | 5-α reductase | 5 alpha Reductase |
| Inhibitors Related | FH1 | Furaneol | Epalrestat | 2-Chloro-1-(4-fluorobenzyl)benzimidazole | Quercitrin hydrate | Dicoumarol | 4-hydroxyphenyl acetate | Lapisteride | Alpha-Estradiol | Isoliquiritigenin | AKR1C1-IN-1 | Kopexil |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | Toxic Compound Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | Inhibitor Library | FDA-Approved Drug Library | Orally Active Compound Library | Lipid Metabolism Compound Library | Bitter Compound library | Bioactive Compounds Library Max | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $35.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $5.00 |
VIP1Y
|
Shanghai Zheng Peptide Plastic Co., Ltd.
|
2026-01-28 | |
| $1.00 |
VIP8Y
|
.GZ HONESTCHEM CO.,LTD
|
2025-10-14 | |
| $20.00 |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2025-07-23 | |
| $5.00 |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2025-07-23 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-30 | ||
| $35.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-05-01 | |
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | ||
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2025-04-17 | ||
|
CHONGQING CHENCHENG PHARMACEUTICAL CO.，LTD.
|
2025-03-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY